top of page
Translational Drug Delivery at
Patel Research Lab
-
Patel research laboratory is involved in exploring novel formulation technologies for delivering next-generation anticancer molecules – protein degraders (PROTACs), hydrophobic small molecules and tumor suppressive gene/mRNA.
-
We have received several prestigious awards at various national meetings for presenting innovative research work on Cancer drug discovery and nanomedicine, tumor targeted nanoparticles, Gene/mRNA delivery, opioid abuse-deterrent formulation, 3D printing, and Vaginal delivery for the prevention of preterm birth and HIV.
Ketan Patel, PhD, is a Professor of Pharmaceutical Sciences at St. John’s University, NY. He has co-authored over 100 research papers demonstrating the role of advanced formulation technologies in improving efficacy and patient compliance. In the last 4 years, He received 3 Federal-National Institute of Health (NIH) grants with over $1.5M in funding for the development of combinatorial nanotherapeutics for the treatment of drug-resistant melanoma, pancreatic cancer, and lung cancer.
Dr. Patel also received a melanoma research scholar award and two industry grants. He has presented/delivered several talks at national and international meetings discussing various formulation technologies. He has mentored over 15 PhDs and MS students in the department of pharmaceutical sciences.
bottom of page